|
1
|
Shlush LI, Zandi S, Mitchell A, Chen WC,
Brandwein JM, Gupta V, Kennedy JA, Schimmer AD, Schuh AC, Yee KW,
et al: Identification of pre-leukaemic haematopoietic stem cells in
acute leukaemia. Nature. 506:328–333. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Eguchi-Ishimae M and Eguchi M: Leukemia.
Gan To Kagaku Ryoho. 43:1341–1345. 2016.In Japanese. PubMed/NCBI
|
|
3
|
Nikkila A, Erme S, Arvela H, Holmgren O,
Raitanen J, Lohi O and Auvinen A: Background radiation and
childhood leukemia: A nationwide register-based case-control study.
Int J Cancer. 139:1975–1982. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Brown N, Finnon R, Manning G, Bouffler S
and Badie C: Influence of radiation quality on mouse chromosome 2
deletions in radiation-induced acute myeloid leukaemia. Mutat Res
Genet Toxicol Environ Mutagen. 793:48–54. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shahrabi S, Khodadi E, Saba F, Shahjahani
M and Saki N: Sex chromosome changes in leukemia: Cytogenetics and
molecular aspects. Hematology. 23:139–147. 2018. View Article : Google Scholar
|
|
6
|
Yamaguchi H: Gene mutations in acute
myeloid leukemia. Rinsho Ketsueki. 57:2535–2542. 2016.
|
|
7
|
Fernando TR, Rodriguez-Malave NI, Waters
EV, Yan W, Casero D, Basso G, Pigazzi M and Rao DS: lncRNA
expression discriminates karyotype and predicts survival in
B-Lymphoblastic leukemia. Mol Cancer Res. 13:839–851. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pan JQ, Zhang YQ, Wang JH, Xu P and Wang
W: lncRNA co-expression network model for the prognostic analysis
of acute myeloid leukemia. Int J Mol Med. 39:663–671. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lammens T, Durinck K, Wallaert A, Speleman
F and Van Vlierberghe P: Long non-coding RNAs in leukemia: Biology
and clinical impact. Curr Opin Hematol. 24:353–358. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee JT: Epigenetic regulation by long
noncoding RNAs. Science. 338:1435–1439. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
St Laurent G, Wahlestedt C and Kapranov P:
The Landscape of long noncoding RNA classification. Trends Genet.
31:239–251. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen S, Liang H, Yang H, Zhou K, Xu L, Liu
J, Lai B, Song L, Luo H, Peng J, et al: Long non-coding RNAs: The
novel diagnostic biomarkers for leukemia. Environ Toxicol
Pharmacol. 55:81–86. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Akhade VS, Pal D and Kanduri C: Long
noncoding RNA: Genome organization and mechanism of action. Adv Exp
Med Biol. 1008:47–74. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dai M, Li S and Qin X: Colorectal
neoplasia differentially expressed: A long noncoding RNA with an
imperative role in cancer. Onco Targets Ther. 11:3755–3763. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Peng W, Fan H, Wu G, Wu J and Feng J:
Upregulation of long noncoding RNA PEG10 associates with poor
prognosis in diffuse large B cell lymphoma with facilitating
tumorigenicity. Clin Exp Med. 16:177–182. 2016. View Article : Google Scholar
|
|
16
|
Meng H, Han L, Hong C, Ding J and Huang Q:
Aberrant lncRNA expression in multiple myeloma. Oncol Res.
26:809–816. 2018. View Article : Google Scholar
|
|
17
|
Zhu H, Zeng Y, Zhou CC and Ye W:
SNHG16/miR-216-5p/ZEB1 signal pathway contributes to the
tumorigenesis of cervical cancer cells. Arch Biochem Biophys.
637:1–8. 2018. View Article : Google Scholar
|
|
18
|
Cao X, Xu J and Yue D: lncRNA-SNHG16
predicts poor prognosis and promotes tumor proliferation through
epigenetically silencing p21 in bladder cancer. Cancer Gene Ther.
25:10–17. 2018. View Article : Google Scholar
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
20
|
Djebali S, Davis CA, Merkel A, Dobin A,
Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F,
et al: Landscape of transcription in human cells. Nature.
489:101–108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Peng WX, Koirala P and Mo YY:
lncRNA-mediated regulation of cell signaling in cancer. Oncogene.
36:5661–5667. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu M, Ohira M, Li Y, Niizuma H, Oo ML, Zhu
Y, Ozaki T, Isogai E, Nakamura Y, Koda T, et al: High expression of
ncRAN, a novel non-coding RNA mapped to chromosome 17q25.1, is
associated with poor prognosis in neuroblastoma. Int J Oncol.
34:931–938. 2009.PubMed/NCBI
|
|
23
|
Christensen LL, True K, Hamilton MP,
Nielsen MM, Damas ND, Damgaard CK, Ongen H, Dermitzakis E, Bramsen
JB, Pedersen JS, et al: SNHG16 is regulated by the Wnt pathway in
colorectal cancer and affects genes involved in lipid metabolism.
Mol Oncol. 10:1266–1282. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cai C, Huo Q, Wang X, Chen B and Yang Q:
SNHG16 contributes to breast cancer cell migration by competitively
binding miR-98 with E2F5. Biochem Biophys Res Commun. 485:272–278.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Thomson DW and Dinger ME: Endogenous
microRNA sponges: Evidence and controversy. Nat Rev Genet.
17:272–283. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bianchi E, Ruberti S, Rontauroli S,
Guglielmelli P, Salati S, Rossi C, Zini R, Tagliafico E, Vannucchi
AM and Manfredini R: Role of miR-34a-5p in hematopoietic progenitor
cells proliferation and fate decision: Novel insights into the
pathogenesis of primary myelofibrosis. Int J Mol Sci. 18:1452017.
View Article : Google Scholar :
|
|
27
|
Lu YF, Cai XL, Li ZZ, Lv J, Xiang YA, Chen
JJ, Chen WJ, Sun WY, Liu XM and Chen JB: lncRNA SNHG16 functions as
an oncogene by sponging miR-4518 and up-regulating PRMT5 expression
in glioma. Cell Physiol Biochem. 45:1975–1985. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chou NH, Lo YH, Wang KC, Kang CH, Tsai CY
and Tsai KW: miR-193a-5p and -3p play a distinct role in gastric
cancer: miR-193a-3p suppresses gastric cancer cell growth by
targeting ETS1 and CCND1. Anticancer Res. 38:3309–3318. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang P, Ji DB, Han HB, Shi YF, Du CZ and
Gu J: Downregulation of miR-193a-5p correlates with lymph node
metastasis and poor prognosis in colorectal cancer. World J
Gastroenterol. 20:12241–12248. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang JT and Wang ZH: Role of miR-193a-5p
in the proliferation and apoptosis of hepatocellular carcinoma. Eur
Rev Med Pharmacol Sci. 22:7233–7239. 2018.PubMed/NCBI
|
|
31
|
Yu T, Li J, Yan M, Liu L, Lin H, Zhao F,
Sun L, Zhang Y, Cui Y, Zhang F, et al: MicroRNA-193a-3p and -5p
suppress the metastasis of human non-small-cell lung cancer by
downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway.
Oncogene. 34:413–423. 2015. View Article : Google Scholar
|
|
32
|
Witalisz-Siepracka A, Gotthardt D,
Prchal-Murphy M, Didara Z, Menzl I, Prinz D, Edlinger L, Putz EM
and Sexl V: NK cell-specific CDK8 deletion enhances antitumor
responses. Cancer Immunol Res. 6:458–466. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yergiyev O, Garib G, Schoedel K, Palekar
A, Bartlett D and Rao UNM: CDK8 expression in extrauterine
leiomyo-sarcoma correlates with tumor stage and progression. Appl
Immunohistochem Mol Morphol. 26:161–164. 2018.
|
